CTI BioPharma Corp.
USD9.10
+0.01 (+0.06%)
CEO
Adam R. Craig
IPO Date
1997-03-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.10
Prev. Close
$9.09
Day Low
$9.09
Day High
$9.10
52W Low
$4.01
52W High
$9.10
Market Cap
$1.20B
Volume
5.56M
| -2.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -132.3% | -90.9% | 0.13 | 3.19 | -4.3 |
| 31 Dec 2019 | FY | 100.0% | -1265.1% | -236.0% | -91.4% | 0.68 | 1.92 | -2.2 |
| 31 Dec 2018 | FY | 96.7% | -111.5% | -50.0% | -32.6% | 0.24 | 3.58 | -1.4 |
| 31 Dec 2017 | FY | 98.6% | -161.7% | -186.4% | -74.1% | 0.64 | 2.44 | -2.4 |
| 31 Dec 2016 | FY | 97.6% | -90.6% | -390.5% | -81.5% | 1.45 | 1.37 | -2.2 |
| 31 Dec 2015 | FY | 88.0% | -741.0% | -229.5% | -82.7% | 1.09 | 1.86 | -2.9 |
| 31 Dec 2014 | FY | 98.5% | -155.4% | -223.6% | -101.2% | 0.42 | 2.22 | -3.8 |
| 31 Dec 2013 | FY | 99.6% | -123.3% | -94.6% | -45.6% | 0.29 | 4.01 | -5.1 |
| -11.4 |
| 30 Sept 2022 | Q3 | 93.7% | -85.7% | 92.8% | -12.7% | -2.92 | 3.26 | -11.3 |
| 30 Jun 2022 | Q2 | 92.6% | -183.8% | 429.7% | -16.8% | -9.35 | 3.60 | -7.1 |
| 31 Mar 2022 | Q1 | 87.9% | -1620.3% | 133.2% | -28.3% | -1.73 | 1.04 | -3.1 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -1014.2% | -52.7% | 13.42 | 1.03 | -1.6 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -62.2% | -23.9% | 1.25 | 1.59 | -2.9 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -31.9% | -25.4% | 0.06 | 4.74 | -2.9 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -64.8% | -40.4% | 0.21 | 2.53 | -3.2 |
| 31 Dec 2020 | Q4 | 0.0% | 0.0% | -37.5% | -25.8% | 0.13 | 3.19 | -4.0 |